Blockchain to save the food industry $31bn by 2024, driven by IoT partnerships

New data from Juniper Research shows that blockchain will enable $31 billion (€27.9 billion) in food fraud savings globally by 2024 by immutably tracking food across the supply chain. Substantial savings in food fraud will be realised from 2021 and compliance costs will be reduced by 30% by 2024. The new research, Blockchain: Key Vertical Opportunities, Trends & Challenges 2019-2030revealed that blockchain, used with IoT sensors and trackers, will reduce retailers’ costs by streamlining supply chains; offering simpler regulatory compliance and efficient food recall process.

Blockchain & the IoT – A powerful Duo

Building on their respective strengths, blockchain, and the IoT can revolutionise the food industry. While IoT solutions link the physical and digital worlds primarily via location tracking sensors and temperature and humidity monitoring, blockchain provides an immutable platform where this data can be stored and accessed by every player in the process.

The research found that the IoT and blockchain will add significant value to players involved in the supply chain, from farmers to retailers and consumers. By replacing lengthy procedures with automated smart contracts, blockchain and the IoT bring cost reductions, risk mitigation and transparency to supply chains. Juniper Research recommends that blockchain vendors seek IoT partnerships to appeal to stakeholders across the food production market.

Article Source

The Fastcomm Advantage

Fastcomm’s business is to build technology platforms that empower its clients to digitally transform their businesses and therefore to understand and address the growing needs of their customers. Our mission is to build long-term technology partnerships that help transform companies, allowing them to concentrate on their core business.

Contraindications, Warnings, Precautions, and Monitoring The product labels for the DHA-containing RxOM3FAs (Lovaza, Omtryg, and Epanovstate that LDL-C levels should be monitored periodically during therapy, as these products may increase LDL-C. Up until this fall, generic Adrenaclick has been the single competitor to EpiPen. Less serious hypokalemia should be evaluated with regard to other coexisting conditions and treated accordingly farmaciasinreceta.org. Epogen may also be used to reduce the chance you will need RBC transfusions if you are scheduled for certain surgeries where a lot of blood loss is expected.

We have a proven track record of understanding disruptive technologies and the effect that they have on businesses. We have built platforms in the IOT and OTT technology domains that allow us to connect people, places and things successfully.

The Fastcomm group of companies has been providing solutions to its partners, since 2002. We have offices in the USA, Europe, and South Africa, allowing us to produce innovative solutions, utilizing know-how and skills acquired worldwide.

Our skilled engineering teams have, over many years, created platforms and building blocks that allow for rapid development and deployment of solutions.

Learn more about our solution offering & partner with us today.